These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6688127)

  • 1. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Young RB; Alon U; Mamunes P
    Pediatrics; 1983 Aug; 72(2):225-33. PubMed ID: 6688127
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
    Chan JC; Young RB; Hartenberg MA; Chinchilli VM
    J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide.
    Santos F; Smith MJ; Chan JC
    Am J Dis Child; 1986 Feb; 140(2):139-42. PubMed ID: 3753816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol.
    Hymes LC; Warshaw BL
    Am J Dis Child; 1984 Dec; 138(12):1125-8. PubMed ID: 6548870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol.
    De Sanctis V; Fiscina B; Ciccone S
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):363-5. PubMed ID: 20679997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of treatment with 1,25-dihydroxyvitamin D3 in children with chronic renal insufficiency].
    Rey Galaán C; Riaño Galán I; del Molino Anta A; Santos Rodríguez F; Málaga Guerrero S; Crespo Hernández M
    An Esp Pediatr; 1987 Nov; 27(5):335-8. PubMed ID: 3439654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Hypoparathyroidism Treatment on the Kidney in Children: Long-Term Retrospective Follow-Up Study.
    Levy I; Licht C; Daneman A; Sochett E; Harrington J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4106-13. PubMed ID: 26323021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
    Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.
    Schaefer K; Umlauf E; von Herrath D
    Am J Kidney Dis; 1992 May; 19(5):460-4. PubMed ID: 1585935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism.
    Lewin IG; Papapoulos SE; O'Riordan JL
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():203s-207s. PubMed ID: 606417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [1 alpha-hydroxycholecalciferol treatment of a 2-year-old child with severe renal osteodystrophy].
    Hansen HE; Christensen MS; Nielsen HE; Johannsen A
    Ugeskr Laeger; 1978 Apr; 140(16):919-21. PubMed ID: 653843
    [No Abstract]   [Full Text] [Related]  

  • 14. [The vitamin D-"hormones". Recent findings on metabolism and therapy].
    Dambacher MA; Girard J; Haas HG
    Internist (Berl); 1972 Apr; 13(4):125-32. PubMed ID: 4555565
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calciferol induced hypercalcemia in renal osteodystrophy.
    Meme JS; Njai DN; Otieno LS; Kalya R
    East Afr Med J; 1980 Oct; 57(10):712-5. PubMed ID: 6971215
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is calcium carbonate a safe phosphate binder in children with chronic renal failure?
    Lal SM; Groshong T
    Int J Artif Organs; 1992 Aug; 15(8):499-501. PubMed ID: 1399100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.